Contact this trialFirst, we need to learn more about you.
JAK2 Inhibitor
AJ1-11095 for Primary Myelofibrosis
Recruiting1 awardPhase 1
Saint Louis, Missouri
This trial is testing a new drug called AJ1-11095 in people who have myelofibrosis and have already been treated with another type of drug. The trial will look at how safe
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.